Posts tagged TerrAscend
Canopy Rivers Portfolio Company TerrAscend Gains Traction in New Jersey Medical Cannabis Market

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) today provided an update that an entity controlled by its portfolio company TerrAscend Corp. (“TerrAscend”) (CSE: TER; OTCQX: TRSSF), NETA NJ LLC (“NETA”), has been selected by the State of New Jersey Department of Health to apply for final approval to operate a vertically integrated Alternative Treatment Center (ATC), which would permit it to cultivate, process and sell medical cannabis in the state.

Read More
Canopy Growth and Canopy Rivers Announce Completion of TerrAscend Restructuring

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth") and Canopy Rivers Inc. ("Canopy Rivers") (TSXV: RIV) are pleased to announce the closing of the previously announced restructuring transaction with TerrAscend Corp. ("TerrAscend") (CSE: TER) pursuant to which TerrAscend restructured its share capital by way of a plan of arrangement under the Business Corporations Act (Ontario) (the "Arrangement").

Read More
Canopy Rivers Announces Significant Contract Manufacturing Agreement Between Portfolio Partners PharmHouse and TerrAscend

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV) is pleased to announce PharmHouse Inc. (“PharmHouse”), has entered into an offtake agreement (the “Agreement”) to supply TerrAscend Canada Inc. (“TerrAscend Canada”), a wholly-owned subsidiary of TerrAscend Corp. (“TerrAscend”) (CSE:TER),  with cannabis products from 20% of the flowering space at its 1.3 million square foot greenhouse facility until December 31, 2021.

Read More